Scientific Analysis: Vitamin D and Omega-3 Supplements Show Stronger Effect on Depression Than Antidepressants
By
mijailt
Pure flour-power. Hearty enough to carry you through lunch.
Summary
This article examines the comparative effectiveness of Vitamin D and Omega-3 supplements versus traditional antidepressants for treating depression. It presents scientific evidence showing that high-dose Omega-3 supplements (1500 mg/day with ≥60% EPA) have an effect size of around 0.6, which is higher than the average effect size of 0.4 for antidepressants. The article provides an accessible deep dive into the scientific research, discussing effect sizes, study methodologies, and the potential benefits of nutritional interventions for mental health.
Key quotes
· 3 pulledThe 'effect size' of the best antidepressants on depression, vs placebo, is around 0.4. (On average; some people respond much better or much worse.) This is like going from a C to a C+.
In contrast: the effect size of 1500 mg/day of '≥60% EPA' Omega-3 supplements is a bit higher, around 0.6. This is like going from a C to a B–.
With uncertainty; at worst, Omega-3's 'only' on par with antidepressants.
You might also wanna read
2026 Regeneron ISEF finalists apply biochemistry and AI to address the mental health crisis
This article highlights how 2026 Regeneron ISEF finalists are using biochemistry, AI, and medical research to develop solutions for the ment
societyforscience.org·4d ago
How the CircaVent project aims to destigmatize mental health and advance brain research
An interview with Matthew Woodworth about the CircaVent project at the Wyss Institute, which aims to destigmatize mental health issues and d
wyss.harvard.edu·4d ago
A Framework for Implementing Family-Focused Mental Health Care
This Viewpoint article outlines a framework for implementing family-focused mental health care, emphasizing the need to address mental healt
doi.org·5d ago
Study Shows Youth Suicide Rates Declined After 988 National Hotline Implementation
A new study found that youth suicide rates in the United States dropped 11% below projections in the two and a half years following the 2022
nytimes.com·1mo ago
Major Lancet Review Finds Medicinal Cannabis Ineffective for Anxiety, Depression, and PTSD
A major systematic review published in The Lancet finds that medicinal cannabis does not effectively treat anxiety, depression, or PTSD, des
Pharmaceutical LSD (MM120) Shows Promise in Treating Generalized Anxiety Disorder in UCSF Clinical Trials
Researchers at UCSF are testing MM120, a pharmaceutical form of LSD, as a treatment for generalized anxiety disorder (GAD). The treatment ha